Price target
103.530.000.00%
The 20 analysts offering 1 year price forecasts for NOT have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to NOT in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NOT EPS for the last quarter is 1.75 CHF despite the estimation of 1.64 CHF. In the next quarter EPS is expected to reach 1.65 CHF. Track more of NOVARTIS AG financials and stay on top of what is up with the company.
In the next quarter NOVARTIS AG revenue is expected to reach 11.73 B CHF. Check out NOVARTIS AG revenue and earnings and make informed decisions.
According to analysts, NOT price target is 103.53 CHF with a max estimate of 122.72 CHF and a min estimate of 83.18 CHF. Check if this forecast comes true in a year, meanwhile watch NOVARTIS AG stock price chart and keep track of the current situation with NOT news and stock market news.
We've gathered opinions of 28 analysts rating NOT stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.